Table 2.
model | input features [resulting number of features] |
placebo group (N=61, conv+: 39, conv-: 22) |
IFN-b group (N=99, conv+: 50, conv-: 49) |
---|---|---|---|
M1 | demographic and clinical
covariates (DC): age, sex, EDSS [3 features] |
56.7% [48.5–64.9%] (p=0.053) [77:63] * |
55.5% [49.0-62.0%] (p=0.051) [98:126] * |
M2 | DC, lesion count, lesion load (i.e.
total lesion volume) [5 f.] |
50.1% [37.6-62.6%] (p=0.537) |
57.6% [47.9-67.3%] (p=0.072) |
M3 | DC, GM volume ratio (GM) [4 f.] | 54.3% [41.8-66.8%] (p=0.261) |
58.6% [48.9-68.3%] (p=0.048) |
M4 | DC, GM, lesion count, lesion load [6 f.] | 60.9% [48.7-73.1%] (p=0.046) |
60.6 [51.0-70.2%] (p=0.020) |
M5 | DC, GM, count, load,
Euler-Poincare characteristic (EP) [7 f.] |
56.6% [44.2-69.0%] (p=0.145) |
54.5% [44.7-64.3%] (p=0.193) |
M6 | whole-brain summaries* of
geometric measures (GEO-brain) [21 f.] |
57.9% [45.5-70.3%] (p=0.126) |
58.5% [48.8-68.2%] (p=0.046) |
M7 | DC, GM, GEO-brain [25 f.] |
67.6% [55.9-79.3%] (p=0.0022) |
64.6% [55.2-74.0%] (p=0.0017) |
M8 | DC, GM by ROI, geometric measures
by ROI (GEO-ROI) [276 f.] |
51.2% [38.7-63.7%] (p=0.468) |
59.6% [49.9-69.3%] (p=0.035) |
M9 | DC, GM, lesion count, subset** of
GEO- brain [15 f.] |
57.8% [45.4-70.2%] (p=0.133) |
70.4% [61.4-79.4%] (p=8e-5) |
M10 | DC, GM by ROI, lesion count,
subset** of GEO-ROI [159 f.] |
50.5% [38.0-63.0%] (p=0.491) |
66.6% [57.3-75.9%] (p=0.0004) |